| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | C6-ceramide | CTRPv2 | pan-cancer | AAC | -0.004 | 0.9 |
| mRNA | CP724714 | GDSC1000 | pan-cancer | AAC | 0.0034 | 0.9 |
| mRNA | NVP-BEZ235 | CTRPv2 | pan-cancer | AAC | 0.0044 | 0.9 |
| mRNA | Pazopanib | GDSC1000 | pan-cancer | AAC | 0.0034 | 0.9 |
| mRNA | lapatinib | gCSI | pan-cancer | AAC | -0.0055 | 0.9 |
| mRNA | alisertib | CTRPv2 | pan-cancer | AAC | -0.0032 | 0.9 |
| mRNA | MLN2238 | CTRPv2 | pan-cancer | AAC | 0.0034 | 0.9 |
| mRNA | tivantinib | CTRPv2 | pan-cancer | AAC | -0.0043 | 0.9 |
| mRNA | Vorinostat | GDSC1000 | pan-cancer | AAC | -0.0029 | 0.9 |
| mRNA | WZ-1-84 | GDSC1000 | pan-cancer | AAC | 0.0049 | 0.9 |